1. 1204 Influence of companion diagnostics on efficacy and safety of targeted anti-cancer drugs. (September 2015) Authors: Ethier, J.L.; Dýez-González, L.; Corrales-Sánchez, V.; Srikanthan, A.; Gascón-Escribano, M.J.; Templeton, A.J.; Vera-Badillo, F.; Seruga, B.; Niraula, S.; Pandiella, A.; Amir, E.; Ocana, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1229 Industry-Sponsored Posters at Major Oncology Conferences: Science or Marketing?. (September 2015) Authors: Guerra, R.B.; Toloi, D.; Tibau, A.; Ocana, A.; Seruga, B.; Vera-Badillo, F.; Amir, E.; Tannock, I.F.; Templeton, A.J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1973 Epidermal growth factor receptor (EGFR) over-expression and outcomes in early breast cancer: A systematic review and meta-analysis. (September 2015) Authors: Vera Badillo, F.E.; Gonzalez-Guerrero, J.F.; Gonzalez-Conchas, G.A.; Rodriguez-Fernandez, I.A.; Verdines-Perez, A.; Templeton, A.; Ocana, A.; Seruga, B.; Tannock, I.F.; Amir, E. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2589 Adjuvant radiation therapy after radical nephrectomy in patients with localized renal cell carcinoma: a systematic review and meta-analysis. (September 2015) Authors: Badillo, F.E. Vera; Gonzalez-Guerrero, J.F.; Rodriguez-Fernandez, I.A.; Gonzalez-Conchas, I.A.; Verdines-Perez, A.; Templeton, A.J.; Ocana, A.; Seruga, B.; Tannock, I.F.; Amir, E. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Association of Aromatase Inhibitors With Coronary Heart Disease in Women With Early Breast Cancer. (21st April 2014) Authors: Seruga, B.; Zadnik, V.; Kuhar, C. Grasic; Marinko, T.; Cufer, T.; Zakotnik, B.; Zorman, D.; Ocana, A.; Amir, E. Journal: Cancer investigation Issue: Volume 32:Number 4(2014) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Association of Aromatase Inhibitors With Coronary Heart Disease in Women With Early Breast Cancer. (21st April 2014) Authors: Seruga, B.; Zadnik, V.; Kuhar, C. Grasic; Marinko, T.; Cufer, T.; Zakotnik, B.; Zorman, D.; Ocana, A.; Amir, E. Journal: Cancer investigation Issue: Volume 32:Number 4(2014) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Association of Aromatase Inhibitors With Coronary Heart Disease in Women With Early Breast Cancer. (21st May 2014) Authors: Seruga, B.; Zadnik, V.; Kuhar, C. Grasic; Marinko, T.; Cufer, T.; Zakotnik, B.; Zorman, D.; Ocana, A.; Amir, E. Journal: Cancer investigation Issue: Volume 32:Number 4(2014) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Evolution in the eligibility criteria of randomized controlled trials for systemic cancer therapies. (February 2016) Authors: Srikanthan, A.; Vera-Badillo, F.; Ethier, J.; Goldstein, R.; Templeton, A.J.; Ocana, A.; Seruga, B.; Amir, E. Journal: Cancer treatment reviews Issue: Volume 43(2016) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Hyperglycaemia and Survival in Solid Tumours: A Systematic Review and Meta-analysis. Issue 4 (April 2018) Authors: Barua, R.; Templeton, A.J.; Seruga, B.; Ocana, A.; Amir, E.; Ethier, J.-L. Journal: Clinical oncology Issue: Volume 30:Issue 4(2018) Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of Geographic Region on Benefit of Approved Anticancer Drugs Evaluated in International Phase III Clinical Trials. Issue 5 (May 2016) Authors: AlHashem, H.Y.; Al-Mubarak, M.; Vera-Badillo, F.E.; Templeton, A.J.; Ocana, A.; Seruga, B.; Amir, E. Journal: Clinical oncology Issue: Volume 28:Issue 5(2016) Page Start: 283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗